Table 2.
Reperfusion therapy and treatment delays among patients with STEMI.
| Characteristics | 2011–2012 | 2016–2018 | P-value |
|---|---|---|---|
| Reperfusion | |||
| STEMI eligible for reperfusion | 1237/1548 (79.9) | 3440/4748 (72.5) | <0.001 |
| Among eligible | |||
| Reperfused | 546/1237 (44.1) | 2698/3440 (78.4) | <0.001 |
| Fibrinolysis | 436/1237 (35.2) | 1250/3440 (36.3) | 0.493 |
| Primary PCI | 110/1237 (8.9) | 1448/3440 (42.1) | <0.001 |
| Specific thrombolytic agents | 347/436 (79.6) | 1186/1250 (94.9) | <0.001 |
| Treatment delays | |||
| Onset-to-FMC (min) | 144 (30–360) | 210 (109–613) | <0.001 |
| Onset-to-FMC time >12 h | 198/1548 (12.8) | 1091/4748 (23.0) | <0.001 |
| FMC-to-fibrinolysis time (min) | 20 (6–48) | 47 (28–80) | <0.001 |
| FMC-to-fibrinolysis ≤30 min | 279/439 (63.6) | 370/1269 (29.2) | <0.001 |
| FMC-to-PCI time (min) | 60 (36–138) | 65 (42–95) | 0.422 |
| FMC-to-PCI ≤90 min | 67/110 (60.9) | 1097/1506 (72.8) | 0.007 |
Data are presented as n/N (%) or median (IQR). FMC: First medical contact; IQR: Interquartile range; PCI: Percutaneous coronary intervention; STEMI: ST elevation myocardial infarction.